In vitro controlled release of alfuzosin hydrochloride using HPMC-based matrix tablets and its comparison with marketed product

Pharmaceutical Development and Technology

Volumn 12, Issue 6, 2007, Pages 621-625

  Nair, Anroop ^a   Gupta, Rachna ^b   Vasanti, Sutrave ^b  

^a MASTERSKILL College of Nursing & Health   (Malaysia)

^b PES COLLEGE OF PHARMACY   (India)

Author keywords

Alfuzosin hydrochloride; Controlled release; Hydroxy propyl methyl cellulose; Matrix tablets

Indexed keywords

ALFUZOSIN; HYDROXYPROPYLMETHYLCELLULOSE; POLYMER;

ARTICLE; BATCH PROCESS; CONTROLLED RELEASE FORMULATION; CORRELATION COEFFICIENT; DRUG MANUFACTURE; DRUG MARKETING; DRUG RELEASE; DRUG SOLUBILITY; KINETICS; MATRIX TABLET; PRIORITY JOURNAL; TABLET COMPRESSION; TABLET FORMULATION;

ADRENERGIC ALPHA-ANTAGONISTS; ANALYSIS OF VARIANCE; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; METHYLCELLULOSE; QUINAZOLINES; TABLETS; VISCOSITY;

EID: 37549065955     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.1080/10837450701563277     Document Type: Article

References (18)

1. Wei, J.T.; Calhoun, E.; Jacobsen, S.J. Urologic diseases in America project: Benign prostatic hyperplasia. J. Urol. 2005, 173, 1256-1261.
2. Salva, P.; Bianchetti G.; Morselli P; Garcia-Teresa G.; Costa J. Pharmacokinetics of alfuzosin after single oral administration to healthy volunteers, of three different doses. Biopharm. Drug Disp. 1992, 13, 583-590.
3. PDR Drug information for hydrochloride. Available at 〈http://www. drugs.com/pdr/alfuzosin_hydrochloride.html〉 (accessed 15 June 2006).
4. US pharmacist new drug review. Available at 〈http://www. uspharmacist.com/oldformat.asp?url=ce/2947/default.htm〉 (accessed on 15 June 2006).
5. Gil, E.C.; Colarte, A.J.; Bataille, B.; Pedraz, J.L.; Rodriguez, F.; Heinamaki, J. Development and optimization of a novel sustained release dextran tablet formulation for Propranolol hydrochloride. Int. J. Pharm. 2006, 317, 32-39.
6. Kuksal, A.; Tiwary, A.K.; Jain, N.K.; Jain, S. Formulation and in vitro, in vivo evaluation of extended-release matrix tablet of Zidovudine: Influence of combination of hydrophilic and hydrophobic matrix former. AAPS Pharm. Sci. Tech. 2006, 7, E1-E9.
7. Li, F.Q.; Hu, J.H.; Deng, J.X.; Su, H.; Xu, S.; Liu, J.Y. In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets. Int. J. Pharm. 2006, 324, 152-157.
8. Keith, M. Compression and consolidation of the powdered solids. In Theory and Practice of Industrial Pharmacy; 3rd Ed.; Lachman, L.; Liberman, H. A.; Kanig, J. L., Eds.; Varghese Publishing House: Mumbai, India, 1991, 66-72.
9. Rouchouse, A.; Manoha, M.; Durand, A.; Thenot, J. P. Direct high-performance liquid chromatographic determination of the entainomers of alfuzosin in plasma on a second generation alpha 1-acid glycoprotein chiral stationary phases. J. Chromatogr. 1990, 506, 601-610.
10. USP XXIV, 17th Ed., Rockville, 1947, MD 2000.
11. Hayashi, T.; Kanbe, H.; Okada, M.; Suzuki, M.; Ikeda, Y.; Onuki, Y.; Kaneko, T.; Sonobe, T. Formulation study and drug release mechanism of a new theophylline sustained-release preparation. Int. J. Pharm. 2005, 304, 91-101.
12. Reza, M.S.; Quadir, M.A.; Haider, S.S. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery. J. Pharm. Pharm. Sci. 2003, 6, 282-91.
13. Yan, G.; Li, H.; Zhang, R; Ding, D. Preparation and evaluation of a sustained-release formulation of nifedipine HPMC tablets. Drug Dev. Ind. Pharm. 2000, 26, 681-686.
14. Takka, S.; Singh B.S.; Sakr, A. Influence of methacrylic acid and hydroxypropylmethyl cellulose on the tablet properties and in vitro release of dextromethorphan hydrobromide, Pharmazie 2003, 58, 886-890.
15. Lee, B.J.; Ryu, S.G.; Cui, J.H. Formulation and release characteristics of hydroxypropyl methylcellulose matrix tablet containing melatonin. Drug Dev. Ind. Pharm. 1999, 25, 493-501.
16. Scheer, M.; tablets and synthesis, US Patent US2006/0062845 A1, March 23, 2006.
17. Tabandeh, H.; Mortazavi, S.A.; Guilani, T.B. Preparation of sustained release matrix tablets of aspirin with ethyl cellulose, Eudragit RS 100 and Eudragit S 100 and studying the release profiles and their sensitivity of tablet hardness. Iranian J. Pharm. Res. 2003, 201-206.
18. Boza, A.; Caraballo, I.; Alvarez-Fuentes, J; Rabasco, A.M. Evaluation of Eudragit® RS-PO and Ethocel® 100 matrices for the controlled release of lobenzarit disodium. Drug Dev. Ind. Pharm. 1999, 25, 229-233.